X
XTNT
vs
S&P 500
S&P 500
Over the past 12 months, XTNT has significantly outperformed S&P 500, delivering a return of +93% compared to the S&P 500's +14% growth.
Stocks Performance
XTNT vs S&P 500
Performance Gap
XTNT vs S&P 500
Performance By Year
XTNT vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Xtant Medical Holdings Inc
Glance View
Xtant Medical Holdings, Inc. designs, and develops orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. The company is headquartered in Belgrade Montana, Montana and currently employs 134 full-time employees. The company went IPO on 2010-06-30. The firm is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. The company offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. The Company’s key spinal implant product lines include Cervical Products, Thoracolumbar Products, Interbody Products, and Interlaminar Stabilization Products.
